TOP STORIES

• REGULATORY Lagevrio, Kerendia Braced for Price Cuts after Cost-Effectiveness Assessment
  March 14, 2024

• REGULATORY Japan Needs Systemic Reform to Balance Universal Coverage and Access to Pricey Meds: LDP Health Affairs Chief
  March 13, 2024

• COMMENTARY With So Many of Its Demands Met, How Will Industry Oppose Off-Year Price Revisions in FY2025?
  March 12, 2024

• REGULATORY PMDA Looks to Rev Up Pediatric and Orphan Drug Initiatives in Next 5-Year Plan: Chief
  March 11, 2024

• ACADEMIA Expert Says RSV Shots Will Have Significant Clinical Impact, Urges Public Funding and NIP Inclusion
  March 8, 2024

• BUSINESS Eisai CEO Confident in Leqembi Uptake, Says 90% of US Hospital Targets to Adopt Med by March-End
  March 8, 2024

• BUSINESS Majority of Drug Makers “Somewhat Satisfied” with FY2024 Revision: Poll
  March 7, 2024

• BUSINESS Removal of PMP Company Indicators Most Popular Policy Change in FY2024 Reform: Poll
  March 7, 2024

• BUSINESS Tsumura Sees 24% Price Hike as Kampo Enjoys Boon in FY2024 Revision: Poll
  March 6, 2024

• REGULATORY Opdivo Faces 15% Slash in Spillover, Re-Pricing to Hit 23 Drugs in FY2024 Revision
  March 5, 2024

• REGULATORY Drug Prices Cut by 4.67% in FY2024 Revision, 314 APIs to Keep Full Prices with PMP
  March 5, 2024

• REGULATORY MHLW to Ask All Generic Makers in Japan to Execute Self-Inspections
  March 4, 2024

• BUSINESS Moderna Japan Taps Kazumasa Nagayama as New President
  March 4, 2024

• REGULATORY Generic Mergers, Product Consolidations Unlikely to Pose Antitrust Issue: FTC Official
  March 1, 2024

• REGULATORY MHLW Sets Out to Beef Up Inspector Skills with Nationwide Sharing of GMP Reports
  February 29, 2024

• BUSINESS Insmed Revs Up for Product Expansion in Japan, Arikayce Frontline Filing Set for 2026 with More to Follow
  February 28, 2024

• BUSINESS Japan Drug Market Tops 11 Trillion Yen for 1st Time Driven by Oncologics: IQVIA
  February 27, 2024

• BUSINESS As Wegovy Hits Japan Market, Novo Re-Stresses Need for Proper Use
  February 26, 2024

• REGULATORY Drug Comparisons in Promotional Activities Allowed under 4 Conditions: MHLW
  February 26, 2024

• REGULATORY Japan to Revisit Vaccine Lot Release Process to Eradicate Double Testing
  February 22, 2024

ページ

• « 先頭
• ‹ Prev
• …
• 45
• 46
• 47
• 48
• 49
• 50
• 51
• 52
• 53
• …
• Next ›
• 最終 »